Two men have been sentenced in federal court for their roles in a $522 million fraud scheme that targeted Medicare, Medicaid, and private insurance companies through fraudulent DNA testing operations.

The defendants used a network of kickbacks and fabricated genetic testing orders to defraud healthcare programs and insurance providers. Court documents indicate the scheme involved submitting false claims for genetic testing services that were either unnecessary or never performed.

Federal prosecutors said one of the suspects attempted to flee the United States before being apprehended by authorities. The Department of Justice pursued the case as part of ongoing efforts to combat healthcare fraud, which costs taxpayers and consumers billions of dollars annually.

The sentencing represents the conclusion of a complex investigation into what officials described as one of the larger healthcare fraud cases in recent years. The scheme specifically exploited the growing market for genetic testing by submitting fraudulent claims to government and private insurance programs.

Healthcare fraud cases have increased in frequency as medical technology advances and new testing procedures become available. Federal authorities continue to investigate similar schemes targeting emerging medical services and diagnostic procedures.